Sinclair IS Pharma CEO grows stake to 8.75m shares

The Chief Executive Officer (CEO) of AIM-listed Sinclair IS Pharma this week added 285,844 to his stake, while fellow board member Stuart Swanson made the modest purchase of 12,774 shares. CEO Chris Spooner paid 30.88p, spending a total of £106,047. His shareholding in the pharmaceutical group now stands at 8.75m, equal to a 2.1% stake. Swanson, a non-executive director, paid 30.5p for his shares, taking his holding to just under 4.54m shares, equal to 1.04% of the issued share capital. The deals come around six weeks after the group reported that it had reduced its half year pre-tax losses by a half and said it remained confident about future progress.Pre-tax losses reduced to £2.5m for the six months ended December 31st from a loss of £5.8m the same time a year earlier. Revenues rose 6% to £24.5m.Top Director BuysSinclair Is Pharma (SPH) Director name: Mr Chris SpoonerAmount purchased: 343,471 @ 30.88p Value: £106,064Spectris (SXS) Director name: Mr Roger StephensAmount purchased: 1,645 @ 2,202.81p Value: £36,236SThree (STHR) Director name: Mr Nadhim ZahawiAmount purchased: 3,182 @ 405.00p Value: £12,887KSK Power Ventur (KSK) Director name: Mr Keith Nicholas HenryAmount purchased: 10,000 @ 110.60p Value: £11,060Top Director SellsWhitbread (WTB) Director name: Mr Louise SmalleyAmount sold: 16,942 @ 4,074.10p Value: £690,234Whitbread (WTB) Director name: Mr Louise SmalleyAmount sold: 16,942 @ 4,074.10p Value: £690,234John Lewis of Hungerford (JLH) Director name: Mr John L LewisAmount sold: 5,000,000 @ 2.00p Value: £100,000NR